Australia markets open in 8 hours 14 minutes

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
140.92+7.04 (+5.26%)
At close: 4:00PM EDT
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
803,395
803,395
60,209
135,068
205,825
Cost of revenue
7,933
7,933
-
-
-
Gross profit
795,462
795,462
-
-
-
Operating expenses
Research development
1,370,339
1,370,339
496,309
454,082
410,459
Selling general and administrative
188,267
188,267
109,620
94,252
64,722
Total operating expenses
1,558,606
1,558,606
605,929
548,334
475,181
Operating income or loss
-763,144
-763,144
-545,720
-413,266
-269,356
Interest expense
9,886
9,886
6,612
-
-
Total other income/expenses net
3,802
3,802
-914
1,835
-1,875
Income before tax
-744,513
-744,513
-514,716
-384,408
-255,996
Income tax expense
2,551
2,551
-695
326
-80
Income from continuing operations
-747,064
-747,064
-514,021
-384,734
-255,916
Net income
-747,064
-747,064
-514,021
-384,734
-255,916
Net income available to common shareholders
-747,064
-747,064
-514,021
-401,857
-269,841
Basic EPS
-
-
-1.55
-1.17
-0.97
Diluted EPS
-
-
-1.55
-1.17
-0.97
Basic average shares
-
-
330,802
328,799
269,649
Diluted average shares
-
-
330,802
328,799
269,649
EBITDA
-
-703,376
-477,083
-388,404
-248,819